(lp0
S'Windtree Therapeutics Completes $10.5 Million Private Offering PR Newswire  - Feb 15, 2017 15, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has completed a $10.5 million private placement&nbsp;...'
p1
aS"Windtree Therapeutics' Aerosolized KL4 Surfactant Reduces Lung Inflammation ... PR Newswire  - Feb 16, 2017 16, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focusing on developing aerosolized KL4 surfactant therapies for respiratory diseases, announced today that data from a preclinical influenza study showed that&nbsp;..."
p2
aS'Discovery Labs Changes Name to Windtree Therapeutics, Inc.  PR Newswire  - Apr 18, 2016 WARRINGTON, Pa., April 18, 2016 /PRNewswire/ -- Discovery Laboratories, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has changed its&nbsp;...Bucks biotech firm changes its name - Philadelphia Business Journal'
p3
aS'Windtree Therapeutics Announces FDA Fast Track Designation for AEROSURF PR Newswire  - Sep 19, 2016 WARRINGTON, Pa., Sept. 19, 2016 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that the U.S.'
p4
aS'Buy Windtree Therapeutics For Its Innovative AEROSURF Technology. Seeking Alpha - May 3, 2016 In this article, we are initiating coverage on Windtree Therapeutics , , a company that is focused on its proprietary synthetic surfactant  that is delivered non-invasively using novel ...'
p5
aS'Windtree Therapeutics Announces Upcoming Presentations at Hot Topics in ... PR Newswire  - Dec 1, 2016 WARRINGTON, Pa., Dec. 1, 2016 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that two abstracts have been&nbsp;...'
p6
aS"Windtree Therapeutics' AEROSURF  Phase 2a Data ... PR Newswire  - Nov 28, 2016 WARRINGTON, Pa., Nov. 28, 2016 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced the Company's previously&nbsp;..."
p7
aS'Windtree Therapeutics Reports Second Quarter 2016 Financial Results and ... PR Newswire  - Aug 10, 2016 10, 2016 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported financial results for the second quarter ended June 30,&nbsp;...'
p8
aS'Windtree Therapeutics, Inc.  Files An 8-K Other Events Market Exclusive - Feb 16, 2017 On February 16, 2017, Windtree Therapeutics, Inc.  will host a conference call and live webcast at 8:00 a.m.'
p9
aS'Windtree Therapeutics, Inc.  Receives Nasdaq Listing Notification StreetInsider.com - Nov 18, 2016 Windtree Therapeutics, Inc.  disclosed the following in a U.S. SEC filing on Friday: Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.'
p10
a.